[HTML][HTML] The NLRP3 inflammasome inhibitor, OLT1177 (dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the …
Background: Activation of the NLRP3 inflammasome is a primary driver of sterile
inflammation in response to myocardial ischemia reperfusion. Pharmacologic inhibitors of …
inflammation in response to myocardial ischemia reperfusion. Pharmacologic inhibitors of …
[引用][C] The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the …
S Toldo, AG Mauro, Z Cutter, BW Van Tassell… - Journal of …, 2019 - cir.nii.ac.jp
The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and
Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse | CiNii Research …
Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse | CiNii Research …
The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse
S Toldo, AG Mauro, Z Cutter… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Activation of the NLRP3 inflammasome is a primary driver of sterile
inflammation in response to myocardial ischemia reperfusion. Pharmacologic inhibitors of …
inflammation in response to myocardial ischemia reperfusion. Pharmacologic inhibitors of …
The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse …
S Toldo, AG Mauro, Z Cutter… - Journal of …, 2019 - europepmc.org
Background Activation of the NLRP3 inflammasome is a primary driver of sterile
inflammation in response to myocardial ischemia reperfusion. Pharmacologic inhibitors of …
inflammation in response to myocardial ischemia reperfusion. Pharmacologic inhibitors of …